Stockscreener 앱 받기
12.31
4.28%
0.50
전일 마감가:
$11.81
열려 있는:
$12.27
하루 거래량:
1.67M
Relative Volume:
0.43
시가총액:
$1.66B
수익:
-
순이익/손실:
$-287.41M
주가수익비율:
-4.0305
EPS:
-3.0542
순현금흐름:
$-157.61M
1주 성능:
+22.29%
1개월 성능:
+28.55%
6개월 성능:
+135.47%
1년 성능:
+182.45%
1일 변동 폭
$11.96
$12.48
1주일 범위
$10.15
$12.48
52주 변동 폭
$2.25
$12.48
Compass Pathways Plc Adr Stock (CMPS) Company Profile
명칭
Compass Pathways Plc Adr
전화
1-716-676-6461
주소
3RD FLOOR, 1 ASHLEY ROAD, CHESIRE
Compare CMPS vs HCA, THC, DVA, FMS, EHC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CMPS
Compass Pathways Plc Adr
|
12.29 | 1.59B | 0 | -287.41M | -157.61M | -3.0542 |
HCA
Hca Healthcare Inc
|
390.77 | 87.42B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
174.08 | 14.97B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
198.74 | 12.74B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
21.68 | 11.62B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
104.53 | 10.41B | 6.07B | 793.80M | 464.40M | 5.9914 |
Compass Pathways Plc Adr Stock (CMPS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-24 | 개시 | B. Riley Securities | Buy |
| 2025-12-10 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-06-23 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2025-02-27 | 개시 | Stifel | Buy |
| 2024-07-23 | 개시 | RBC Capital Mkts | Outperform |
| 2024-04-01 | 개시 | Morgan Stanley | Overweight |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2022-11-21 | 재개 | Berenberg | Buy |
| 2022-11-01 | 개시 | Loop Capital | Buy |
| 2021-10-29 | 개시 | Oppenheimer | Outperform |
| 2021-07-13 | 개시 | Citigroup | Buy |
| 2021-06-28 | 개시 | Maxim Group | Buy |
| 2021-05-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-04-01 | 개시 | ROTH Capital | Buy |
| 2020-10-14 | 개시 | H.C. Wainwright | Buy |
| 2020-10-13 | 개시 | Berenberg | Buy |
| 2020-10-13 | 개시 | Canaccord Genuity | Buy |
| 2020-10-13 | 개시 | Cowen | Outperform |
| 2020-10-13 | 개시 | Evercore ISI | Outperform |
모두보기
Compass Pathways Plc Adr 주식(CMPS)의 최신 뉴스
COMPASS Pathways Plc Q1 2026 Earnings: Narrower Loss Provides Hope Amid Pre-Revenue StageLow Growth Earnings - Newser
CMPS Stock Quote Price and Forecast - CNN
Compass Pathways stock hits 52-week high at 11.65 USD - Investing.com
Compass Pathways Eyes Q4 FDA Filing for Psilocybin Depression Drug After Phase 3 Wins - Barchart.com
Why LiveRamp Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket - Sahm
Is Compass Pathways (CMPS) outperforming other medical stocks this year? - MSN
Compass Pathways Reports Strong Q1 Results, Shares Surge - Sahm
Why COMPASS Pathways (CMPS) Is Up 13.1% After FDA Fast-Track Moves For COMP360 Profit Shift - Sahm
Compass Pathways stock hits 52-week high at 10.22 USD - Investing.com India
Compass Pathways Q1 Earnings Call Highlights - Barchart.com
Compass Pathways stock surges 8% on beating estimates as FDA accelerates review - Investing.com India
Compass Pathways stock surges 8% on beating estimates as FDA accelerates review By Investing.com - Investing.com South Africa
Compass Pathways Announces First Quarter 2026 Financial Results and Business Highlights - Via TT
What makes COMPASS Pathways PLC sponsored ADR (CMPS) a strong momentum stock: Buy now? - MSN
How much upside is left in COMPASS Pathways (CMPS)? Wall Street analysts think 136% - MSN
Compass Pathways earnings on deck as psychedelic approval nears By Investing.com - Investing.com South Africa
Compass Pathways earnings on deck as psychedelic approval nears - Investing.com
Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
These 3 Psychedelic Stocks Activated After Trump's Executive Order - MarketBeat
CMPS Stock Price, Quote & Chart | COMPASS PATHWAYS PLC (NASDAQ:CMPS) - ChartMill
BIT Capital GmbH Raises Stock Holdings in Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat
This AMD Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Sahm
Trump Wants to Give Psychedelics Stocks a Boost. Can This Leading Company Deliver? - Barchart
Error: Response status code does not indicate success: 503 (Service Unavailable). - Yahoo Finance
These 3 Psychedelic Stocks Activated After Trump’s Executive Order - Investing.com
This Walker & Dunlop Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Sahm
Compass Pathways stock gets Morgan Stanley overweight rating on FDA voucher - Investing.com India
Compass Pathways stock gets Morgan Stanley overweight rating on FDA voucher By Investing.com - Investing.com South Africa
Compass Pathways (NASDAQ:CMPS) Sees Large Volume IncreaseHere's Why - MarketBeat
Compass Pathways shares rise as FDA grants rolling review for depression drug By Investing.com - Investing.com South Africa
FDA grants priority voucher to Compass for psilocybin treatment By Investing.com - Investing.com India
FDA grants priority voucher to Compass for psilocybin treatment - Investing.com
Compass Pathways shares rise as FDA grants rolling review for depression drug - Investing.com
Is COMPASS Pathways (CMPS) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Compass Pathways (NASDAQ:CMPS) Stock Price Up 7.7%Here's What Happened - MarketBeat
Compass Pathways Plc Adr (CMPS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.10%
0.00%
자본화:
|
볼륨(24시간):